Meropenem Anfarm

Meropenem, the active ingredient in Meropenem Anfarm, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, and severe sepsis in hospitalized patients.

GNH USA supplies Meropenem Anfarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

Complicated intra‑abdominal infections: provides bactericidal activity to eradicate the infection. Complicated urinary tract infections: eliminates resistant uropathogens causing severe UTIs. Nosocomial pneumonia: treats hospital‑acquired lung infections resistant to other antibiotics. Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria. Severe sepsis and septic shock: offers rapid bacterial clearance in critically ill patients.

Adverse reactions may occur with meropenem therapy and are categorized by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Rash or pruritus - Headache - Elevated liver enzymes - Infusion site erythema or phlebitis

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment or CNS disorders - Clostridioides difficile‑associated colitis - Anaphylaxis or severe hypersensitivity reactions - Severe neutropenia or leukopenia - Renal toxicity or acute kidney injury - Hypersensitivity leading to Stevens‑Johnson syndrome or toxic epidermal necrolysis

Meropenem should be used with caution in specific clinical situations and patient populations.

Renal function: assess creatinine clearance and adjust dose if needed. Hepatic impairment: monitor liver enzymes during therapy. Seizure risk: avoid in patients with a history of seizures or CNS disorders. Valproic acid co‑administration: may increase neurotoxicity; monitor closely. Pregnancy: safety category unknown; weigh benefits against potential risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring avoidance or monitoring.

Major Interactions (Avoid): - Valproic acid: reduces plasma levels and may precipitate seizures. - Probenecid: decreases renal clearance, increasing meropenem exposure. - Loop diuretics: may enhance nephrotoxic potential.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - NSAIDs: may impair renal clearance; observe kidney parameters. - Anticoagulants (e.g., warfarin): possible alteration of INR; check coagulation status regularly.